Adjunctive Dulaglutide in Relapsing-Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial.

Šiarnik P, Rádiková Ž, Kollár B, Kutšálová M, Penesová A, Havranová A, Imrich R, Vlček M, Žitňanová I, Krastev G, Turčáni P

Open source

DOI: 10.1007/s40120-026-00982-4
Published: 2026 Aug
Container: Neurology and therapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40120-026-00982-4,
  title = {Adjunctive Dulaglutide in Relapsing-Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial.},
  author = {Šiarnik P and Rádiková Ž and Kollár B and Kutšálová M and Penesová A and Havranová A and Imrich R and Vlček M and Žitňanová I and Krastev G and Turčáni P},
  year = {2026},
  journal = {Neurology and therapy},
  doi = {10.1007/s40120-026-00982-4},
  url = {https://doi.org/10.1007/s40120-026-00982-4}
}

RIS

TY  - JOUR
TI  - Adjunctive Dulaglutide in Relapsing-Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial.
AU  - Šiarnik P
AU  - Rádiková Ž
AU  - Kollár B
AU  - Kutšálová M
AU  - Penesová A
AU  - Havranová A
AU  - Imrich R
AU  - Vlček M
AU  - Žitňanová I
AU  - Krastev G
AU  - Turčáni P
PY  - 2026
JO  - Neurology and therapy
DO  - 10.1007/s40120-026-00982-4
UR  - https://doi.org/10.1007/s40120-026-00982-4
ER  -

APA

P, Š., Ž, R., B, K., M, K., A, P., A, H., R, I., M, V., I, Ž., G, K., & P, T. (2026). Adjunctive Dulaglutide in Relapsing-Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial.. Neurology and therapy. https://doi.org/10.1007/s40120-026-00982-4

Source records

pubmed · retrieved 2026-09-27T08:50:46.003Z